Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Filings indexed 1,395 across all filing types
Latest filing 2015-05-04 Director's Dealing
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2015-05-04 English
FORM 4 SUBMISSION
Director's Dealing
2015-05-04 English
10-Q
Interim / Quarterly Report Q1 2015
2015-04-28 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 28, 2015, reporting the company's financial results for the quarter ended March 31, 2015. It specifically references a press release titled 'IDEXX Laboratories Announces First Quarter Results' as Exhibit 99.1. The text indicates that the Form 8-K and the press release are furnished under Item 2.02 (Results of Operations and Financial Condition). The document is relatively short (3358 characters) and primarily serves to announce the earnings release rather than providing detailed financial statements or analysis itself. According to the rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER). Therefore, this filing is best classified as an Earnings Release (ER).
2015-04-28 English
DEFR14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a definitive proxy statement filed on Schedule 14A with the SEC, related to the 2015 Annual Meeting of Stockholders of IDEXX Laboratories, Inc. It includes detailed information about the meeting agenda, proposals to be voted on, corporate governance, executive compensation, director nominations, and voting procedures. The document is not an annual report, earnings release, or other financial report but is specifically a proxy solicitation document. The presence of the Schedule 14A header and the content focused on proxy solicitation and shareholder voting clearly identifies this as a Proxy Solicitation & Information Statement filing.
2015-04-10 English
AUTO-GENERATED PAPER DOCUMENT
Annual Report
2015-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.